TERNS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.91 USD | +5.82% |
|
+7.68% | -24.35% |
| Apr. 10 | Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer | CI |
| Mar. 27 | UBS Trims Terns Pharmaceuticals Price Target to $18 From $19, Maintains Buy Rating | MT |
Chart calendar Terns Pharmaceuticals, Inc.
412d7a767e09ab7ffcc81.dP1SE8kI1A53oQSmPfE7dYaEMKBtM4eo0-ygGHJnoBk.N8wlYLxA5WMcy37LSZRZB6vQQfg5cf7LoYjjbT0R2EZZyj8kkUyxag3RNA~bb70a1c7c33077e10ba7f6b1315c7464
Upcoming events on Terns Pharmaceuticals, Inc.
Past events on Terns Pharmaceuticals, Inc.
| 2024-03-20 11:00 am | BMO Obesity Summit |
| 2024-03-14 04:05 pm | Q4 2023 Earnings Release |
| 2024-03-04 12:50 pm | TD Cowen Health Care Conference |
| 2024-01-10 04:30 pm | JPMorgan Healthcare Conference |
| 2023-12-06 12:30 pm | JMP Securities Hematology and Oncology Summit |
| 2023-11-29 01:45 pm | Evercore ISI HealthCONx Conference |
| 2023-11-15 04:30 am | Jefferies London Healthcare Conference |
| 2023-11-14 08:05 am | Q3 2023 Earnings Release |
| 2023-11-13 04:00 pm | American Association for the Study of Liver Diseases Conference |
| 2023-11-13 02:00 pm | American Association for the Study of Liver Diseases Conference |
| 2023-11-08 04:30 pm | UBS Biopharma Conference |
| 2023-10-24 02:30 pm | H.C. Wainwright NASH Investor Conference |
| 2023-09-11 11:30 am | H.C. Wainwright Global Investment Conference |
| 2023-09-06 | Wells Fargo Healthcare Conference |
| 2023-08-08 04:30 pm | Terns DUET Top-line Results Call |
| 2023-08-08 04:15 pm | Q2 2023 Earnings Release |
| 2023-07-25 11:30 am | Investor Meeting - Key Opinion Leader |
| 2023-06-29 11:00 am | Terns Obesity Franchise Webinar |
| 2023-06-28 11:30 am | Piper Sandler Inaugural Obesity Investor Day |
| 2023-06-25 02:30 pm | American Diabetes Association Scientific Session |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 1,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,67 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -36,6 -39,4 7.14% | -49,3 -52,6 6.26% | -61,5 -63,0 2.29% | -102 -102 -0.58% | -113 |
|
EBIT Million USD | Released Forecast Spread | -70,2 | -37,0 -39,5 6.32% | -49,9 -51,6 3.43% | -62,0 -63,5 2.25% | -103 -102 -0.38% | -114 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -39,8 -41,7 4.54% | -49,7 -52,7 5.7% | -60,0 -62,5 4.09% | -90,0 -95,0 5.32% | -109 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -29,4 -41,2 28.83% | -50,2 -52,8 4.95% | -60,3 -62,5 3.46% | -90,2 -94,3 4.36% | -108 |
|
EPS USD | Released Forecast Spread | -26,7 | -103 -89,3 -15.23% | -2,21 -2,32 4.83% | -1,67 -1,85 9.76% | -1,27 -1,32 4.11% | -1,39 |
| Announcement Date | 10/11/20 | 30/03/21 | 03/03/22 | 27/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 1,95 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -13,8 -20,0 31.18% | -13,7 -18,0 23.98% | -13,9 -18,0 22.52% | -17,2 -18,0 4.56% | -16,7 -18,0 7.17% | -24,1 -16,5 -45.69% | -21,1 -20,0 -5.44% | -33,1 -21,0 -57.68% | -24,0 -22,0 -9.03% | -26,0 | -28,0 | -29,0 | -30,0 | |
|
EBIT Million USD | Released Forecast Spread | -13,9 -15,6 10.95% | -13,8 -16,3 15.24% | -14,1 -15,3 8.24% | -17,3 -15,8 -9.26% | -16,8 -18,3 8.04% | -24,2 -17,0 -41.84% | -21,2 -24,4 13.4% | -33,2 -24,1 -37.82% | -24,1 -23,6 -2.04% | -27,6 | -28,2 | -31,3 | -29,1 | -25,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,8 -16,8 17.53% | -13,8 -17,1 19.34% | -13,9 -16,5 15.36% | -16,8 -16,4 -2.71% | -15,5 -17,9 13.51% | -21,5 -16,1 -33.42% | -17,8 -22,0 18.97% | -29,7 -21,5 -38.2% | -21,0 -21,3 1.42% | -26,8 | -27,6 | -31,7 | -27,8 | |
|
Net income Million USD | Released Forecast Spread | -14,2 -16,8 14.94% | -13,8 -17,1 19.22% | -13,9 -16,5 15.32% | -16,8 -16,4 -2.75% | -15,8 -17,9 11.76% | -21,5 -16,1 -33.37% | -17,9 -22,8 21.48% | -29,8 -21,5 -38.44% | -21,0 -21,3 1.21% | -26,8 | -27,6 | -31,7 | -27,8 | |
|
EPS USD | Released Forecast Spread | -0,56 -0,66 15.7% | -0,55 -0,67 18.06% | -0,55 -0,63 12.42% | -0,44 -0,51 13.33% | -0,29 -0,42 30.78% | -0,31 -0,26 -19.55% | -0,25 -0,33 24.76% | -0,42 -0,30 -41.9% | -0,29 -0,29 -0.03% | -0,35 | -0,35 | -0,38 | -0,33 | -0,32 |
| Announcement Date | 03/03/22 | 16/05/22 | 08/08/22 | 09/11/22 | 27/03/23 | 15/05/23 | 08/08/23 | 14/11/23 | 14/03/24 | - | - | - | - | - |
More events
Past sector events for Terns Pharmaceuticals, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TERN Stock
- Calendar Terns Pharmaceuticals, Inc.
